July 15, 2021
- July 7, 2021
Market surveillance for anticipating crises and opportunitiesUnderstanding your company’s position and being aware of where the market is heading are the tools that allow you to shape the present and transform the future as we adapt to it.
- July 6, 2021
Sustainable mobility and infrastructuresPropose from civil society initiatives that favor mobility, infrastructures and the development of SMART CITIES
- June 28, 2021
"Agile is going to be the word par excellence in the field of business"For iconn's director of transformation, Abraham Ibarra, the key to the future of 'retail' lies in hybridization, both in remote and face-to-face work models and in physical and online purchasing patterns, and affirms that digital transformation has allowed them to reduce the rate of employee turnover
- June 24, 2021
Lean and Agile: the way forward for companies in optimizing their business processesThe pandemic has highlighted that agility and speed in work structures are important to overcome economic difficulties and to face new competitors
- June 15, 2021
"Tech companies must understand that patients are not numbers."Organon Latin America's medical director, Juan Marques, appreciates that the pandemic has accelerated the healthcare sector's digitalization, but is cautious when it comes to implementing technologies that could put patients' lives and privacy at risk, and stresses that no medical innovation should ever neglect the human touch.
- June 14, 2021
Silver economy: mapping of actors and trends in Latin America and the CaribbeanThe sectors and markets of the silver economy are differentiated by their size and degree of maturity
- June 8, 2021
What the ESG funds could be done for the planet (and for your company)In 2021, transparency, ethical values and sustainability are key to ensuring that your company secures financing. The economic crisis caused by COVID-19 has prompted a shift towards a green economy, which in turn brings with it a new philosophy of investment.
- June 3, 2021
"I'm certain there will be a cure for cancer someday."According to Novartis Oncology Spain's Managing Director, José Marcilla, the pharmaceutical sector must provide value to its customers and stakeholders through innovation, explaining that personalized medicine and immunotherapy are providing great advances in the treatment of oncology patients.
- May 17, 2021
"The consumer is starting to look at where products are made."The president of pharmaceutical company Cantabria Labs, Juan Matji, explains how his industry and company are being transformed by new innovations, and he predicts greater societal consideration of where manufacturing takes place after suffering from its " dependence" on foreign supply chains during lockdown.
- May 13, 2021
How to combat the impact of COVID-19 disinformationThe spread of false information has been a constant throughout the pandemic, and has damaged the public's confidence in science and the institutions related to it. Nevertheless, it is possible to regain credibility through appropriate communication and transparency.
- May 5, 2021
Promoting an energy transition plan and re-industrialization of the countryWe propose initiatives that favour the construction of a more robust industrial fabric with a greater impact on the economy, placing special emphasis on creating a strategic plan focused on energy transition as a pillar on which to leverage re-industrialisation
- May 4, 2021
"An anonymous person can blow up your digital life in 10 minutes."Online’ reputation has become society's new currency, according to RepScan CEO Josep Coll, whose company is committed to offering digital defence rights to citizens. His ‘start-up’ scours the internet for fake and illegal content in order to remove it and prevent it from damaging its clients' online image.
- April 28, 2021
Co-creating solutions to the current challenges of foundationsAnalysis of the solutions to the challenges presented at the event "Co-creating solutions to the current challenges of foundations" that took place on 11 March 2021
- April 20, 2021
"AI saves time, but human brilliance is still necessary to advance beyond that."Technology, open innovation and public-private collaboration are essential to the pharmaceutical sector's progress, says HR Business Partner for Human Resources at Sanofi, David Reyero, who also highlights the importance of joining forces and intelligence between different professionals and technological tools.
- April 19, 2021
The new innovation opened up after the coronavirusThe pandemic has prevented companies and start-ups from interacting as they once did within the beneficial framework of open innovation. With an optimistic outlook, we delve into how organisations can and must reinvent themselves to ensure that their relationships with third parties remain fruitful.
- April 5, 2021
"In the next few years there will be professionals, not professions."For Eva Roca, head of Talent Acquisition at Schneider Electric Iberia, dealing with uncertainty is part of the new business normal, companies must empower employees to drive change in an agile way and learn from their inevitable mistakes.
- April 2, 2021
COVID-19 vaccines, a breakthrough for pharmaceutical innovationThe history of the vaccine dates back a long way. In 1976, the physician, Edward Jenner, tried to inoculate an eight-year-old boy with a small amount of bovine smallpox-infected material. Months later, he injected the virus into the vhild and found that he had developed immunity. Although they were initially dismissed by sceptics, the vaccines are now a success story. The World Health Organisation (WHO) figures corroborate this growing trend in longevity: humans are living on average six years longer than at the beginning of this century, with the average life expectancy now standing at 73 years.